title: Survivin expression in primary malignant melanoma of the esophagus.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Mamori
authors.forename: Fumiaki
authors.initials: F
authors.lastname: Kahara
authors.forename: Katsuhiro
authors.initials: K
authors.lastname: Ohnishi
authors.forename: Akihiko
authors.initials: A
authors.lastname: Takeda
authors.forename: Akihiro
authors.initials: A
authors.lastname: Higashida
authors.forename: Cho
authors.initials: C
authors.lastname: Ashida
authors.forename: Hajime
authors.initials: H
authors.lastname: Yamada
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000235:genetics; D001706:Biopsy; D015853:Cysteine Proteinase Inhibitors / Q000235:genetics; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D051034:Inhibitor of Apoptosis Proteins; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D008869:Microtubule-Associated Proteins / Q000235:genetics*; D008875:Middle Aged; D009285:Naphthoquinones / Q000627:therapeutic use; D000077022:Survivin; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; C107489:BIRC5 protein, human; D014408:Biomarkers, Tumor; D015853:Cysteine Proteinase Inhibitors; D007093:Imidazoles; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins; D009285:Naphthoquinones; D000077022:Survivin; C523798:sepantronium